DSIP (Delta Sleep-Inducing Peptide): Research Overview

Overview

DSIP (Delta Sleep-Inducing Peptide) is a synthetic nonapeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, first isolated from the cerebral venous blood of rabbits during electrically induced sleep. It crosses the blood-brain barrier via a specific high-affinity saturable transport mechanism, distinguishing it from many neuropeptides that require alternative delivery routes to reach the central nervous system. Despite its name, DSIP’s research scope extends well beyond sleep: published literature covers anticonvulsant activity, analgesic effects via modulation of opioid receptor-enkephalin interactions, antioxidant activity, and stress-response modulation, alongside its originally studied sleep-architecture effects.

Citation: Kastin A.J., et al., Studies on BBB transport

History

DSIP was first detected and isolated by Monnier and colleagues in the early 1970s from hemodialysates of rabbits subjected to electrical stimulation of the intralaminal thalamus to induce sleep, making it one of the first sleep-associated substances isolated directly from brain-derived material. Its mechanism of action has remained incompletely characterized despite five decades of study — human sleep-EEG studies have produced mixed results, with a small double-blind study in chronic insomniac patients reporting improved sleep efficiency and reduced sleep latency, while other studies found only minor effects. Research since has broadened considerably into anticonvulsant, analgesic, and stress-modulation contexts in animal models.

Citation: Schoenenberger G.A., 1984

Structure

Research Findings

DSIP has been studied in animal models for sleep architecture, seizure activity, pain signaling, and stress response, with a mechanism of action that remains incompletely defined.

Key Areas of Research

• Sleep: Slow-wave sleep promotion in several species, sleep efficiency and latency effects in a small human insomnia study
• Neurological: Anticonvulsant activity in seizure models, potentiation of valproate’s anticonvulsant effect
• Analgesic: Modulation of enkephalin-opioid receptor interactions, centrally administered antinociceptive effects
• Stress/protective: Reported antioxidant activity, modulation of resistance to emotional stress, antiedematic effects in toxic brain edema models

Summary: Together, these findings position DSIP as a neuropeptide with a broader research profile than its name suggests, spanning sleep, seizure, pain, and stress-response biology in animal and limited human studies. Its blood-brain-barrier permeability has made it a useful research tool for studying CNS peptide transport specifically, independent of its behavioral effects. Human sleep research findings have been inconsistent across studies, and its precise mechanism of action remains unresolved.

Citation: Kastin A.J., et al.

References

• Schoenenberger G.A. (1984). Characterization, properties, and multivariate functions of delta-sleep-inducing peptide (DSIP). European Neurology.
• Graf M.V., Kastin A.J. (1986). Delta-sleep-inducing peptide (DSIP): an update. Peptides.
• Bondarenko T.I., et al. (2011). Mechanism of geroprotective action of delta-sleep inducing peptide. Advances in Gerontology.
• Schneider-Helmert D., Schoenenberger G.A. (1992). Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study. Neuropsychobiology.

Certificate of Analysis

Every lot is independently tested and lot-matched. View Certificates of Analysis

Related Research Categories